FDA Clears ELITechGroup’s Herpes Assays

November 2, 2018

ELITechGroup’s real-time PCR assays for detecting herpes simplex viruses 1 & 2  has been given 510(k) clearance by the FDA.

The assays, which are used with the company’s InGenius sample-to-result device, can detect and differentiate between herpes simplex viruses 1 & 2.

The assays analyze nucleic acid obtained from the patient’s lesions on the skin, genital, lips or mouth.

View today's stories